The Vice-Chancellor gives notice that she has received with gratitude a benefaction of $1,893,741, payable over three years, from the Board of Cambridge in America. The benefaction is made possible following a generous gift from the Genzyme Corporation and is to be used to support two single term Clinical Ph.D. Fellowships in Clinical Neuroscience and to contribute towards the endowment of a Clinical Lectureship in Neuroimmunology in the Department of Clinical Neurosciences.
The Council is submitting a Grace to the Regent House (Grace 1, p. 561) for the approval of regulations to govern the Clinical Lectureship.